Jane Street Group LLC Sells 8,849 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Jane Street Group LLC reduced its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 25.5% during the 3rd quarter, HoldingsChannel reports. The firm owned 25,918 shares of the company’s stock after selling 8,849 shares during the quarter. Jane Street Group LLC’s holdings in U.S. Physical Therapy were worth $2,193,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of USPH. Canada Pension Plan Investment Board acquired a new stake in U.S. Physical Therapy in the 2nd quarter valued at $28,000. Innealta Capital LLC acquired a new position in U.S. Physical Therapy during the second quarter worth $30,000. Quest Partners LLC lifted its holdings in shares of U.S. Physical Therapy by 2,808.3% during the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after acquiring an additional 337 shares during the period. Quarry LP boosted its stake in shares of U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock valued at $48,000 after purchasing an additional 478 shares in the last quarter. Finally, Ridgewood Investments LLC bought a new stake in shares of U.S. Physical Therapy in the 2nd quarter worth about $51,000.

Insider Activity

In other U.S. Physical Therapy news, Director Nancy Ham sold 1,172 shares of the firm’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $96.72, for a total transaction of $113,355.84. Following the transaction, the director now owns 1,112 shares in the company, valued at approximately $107,552.64. This trade represents a 51.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Carey P. Hendrickson sold 516 shares of the stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the sale, the chief financial officer now owns 20,469 shares in the company, valued at $1,970,141.25. This represents a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 7,412 shares of company stock valued at $706,605. Company insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Price Performance

USPH opened at $89.84 on Tuesday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The stock has a market capitalization of $1.36 billion, a P/E ratio of 95.57, a price-to-earnings-growth ratio of 4.23 and a beta of 1.46. The company’s 50 day simple moving average is $90.96 and its 200-day simple moving average is $89.61. U.S. Physical Therapy, Inc. has a one year low of $76.18 and a one year high of $113.63.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 15th were given a $0.44 dividend. The ex-dividend date was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a yield of 1.96%. U.S. Physical Therapy’s payout ratio is 187.23%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on USPH shares. JPMorgan Chase & Co. lifted their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Tuesday, December 3rd. Barrington Research reiterated an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. JMP Securities initiated coverage on U.S. Physical Therapy in a report on Monday, December 16th. They set an “outperform” rating and a $113.00 price target for the company. Finally, Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $100.00 to $115.00 in a research note on Monday, December 16th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $114.00.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.